← Back to Search

Behavioral Intervention

Home-Based Pulmonary Rehabilitation for COPD

N/A
Waitlist Available
Led By Roberto P Benzo, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 40+
Be older than 18 years old
Must not have
- Inability to walk (orthopedic-neurologic problems or confined to bed)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is comparing the effectiveness of two types of pulmonary rehabilitation programs.

Who is the study for?
This trial is for individuals over 40 years old who have been hospitalized due to Chronic Obstructive Pulmonary Disease (COPD) and are eligible for Pulmonary Rehabilitation (PR). Participants must feel confident (scoring above a 5 on a self-efficacy scale of 1-10) about using the system daily. Those unable to walk due to orthopedic-neurologic issues or being bedridden cannot join.
What is being tested?
The study compares two approaches: home-based PR with new technology and health coaching, versus traditional referral to center-based PR which may also offer telehealth options. The goal is to see which method better encourages patients to stick with their rehabilitation after leaving the hospital.
What are the potential side effects?
Since this intervention involves exercise and health coaching rather than medication, side effects might include muscle soreness or fatigue from physical activity. However, specific side effects will depend on individual health conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 40 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot walk due to orthopedic or neurologic reasons, or I am bedridden.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence to Pulmonary Rehabilitation
Secondary study objectives
Daily Physical Activity
Duke-UNC Functional Social Support Questionnaire (FSSQ)
Health Care Utilization
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention- Home Pulmonary RehabilitationExperimental Treatment1 Intervention
Participants enrolled in the intervention arm will be offered a Home-based pulmonary rehabilitation program with health coaching.
Group II: Control- ChoiceActive Control1 Intervention
This arm receives the standard of care which includes the choice of PR at a facility or through telehealth. Center based PR involves attending a medical center gym where they can do exercises and receive disease specific education. Telehealth PR is delivered virtually through the computer or telephone.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intervention- Home-based Pulmonary Rehabilitation
2018
N/A
~10

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,922 Previous Clinical Trials
47,760,442 Total Patients Enrolled
Mayo ClinicLead Sponsor
3,326 Previous Clinical Trials
3,059,198 Total Patients Enrolled
Roberto P Benzo, MDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
36 Total Patients Enrolled

Media Library

Home-based Pulmonary Rehabilitation (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04521608 — N/A
Chronic Obstructive Pulmonary Disease Research Study Groups: Control- Choice, Intervention- Home Pulmonary Rehabilitation
Chronic Obstructive Pulmonary Disease Clinical Trial 2023: Home-based Pulmonary Rehabilitation Highlights & Side Effects. Trial Name: NCT04521608 — N/A
Home-based Pulmonary Rehabilitation (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04521608 — N/A
~60 spots leftby Nov 2025